Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
ClinicalTrials.gov study NCT06126406. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Y
ClinicalTrials.gov study NCT05621291. IPD Sharing: YES. Countries: 1. Publications: 0.
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT05474378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major
ClinicalTrials.gov study NCT00480506. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
ClinicalTrials.gov study NCT04082910. IPD Sharing: NO. Countries: 1. Publications: 0.
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
ClinicalTrials.gov study NCT04903080. IPD Sharing: NO. Countries: 2. Publications: 0.
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07361029. IPD Sharing: YES. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
ClinicalTrials.gov study NCT03076437. IPD Sharing: NO. Countries: 1. Publications: 0.
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
ClinicalTrials.gov study NCT04897321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
ClinicalTrials.gov study NCT01192464. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
ClinicalTrials.gov study NCT05822427. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocyti
ClinicalTrials.gov study NCT04223765. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute
ClinicalTrials.gov study NCT03126864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
ClinicalTrials.gov study NCT07087847. IPD Sharing: NO. Countries: 1. Publications: 0.
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
ClinicalTrials.gov study NCT02905188. IPD Sharing: NO. Countries: 1. Publications: 0.
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
ClinicalTrials.gov study NCT04540380. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma
ClinicalTrials.gov study NCT06827886. IPD Sharing: NO. Countries: 1. Publications: 0.
AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells
ClinicalTrials.gov study NCT04169022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy
ClinicalTrials.gov study NCT04870853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)
ClinicalTrials.gov study NCT06698484. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.